Allogeneic MSC Treatment for Pulmonary Emphysema

PHASE2UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

September 1, 2021

Study Completion Date

June 1, 2022

Conditions
Pulmonary EmphysemaMesenchymal Stromal Cells
Interventions
GENETIC

Allogeneic MSC

These MSCs will originate from bone marrow that will be aspirated from healthy volunteer donors screened by a trained physician of the center for stem cell therapy of LUMC

DRUG

Placebo

The placebo will be an equivalent volume NaCl 0,9% and DMSO 5%

Trial Locations (1)

2333 ZA

RECRUITING

Department of Pulmonology, Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

Amsterdam UMC, location VUmc

OTHER

lead

Leiden University Medical Center

OTHER